Repligen バランスシートの健全性
財務の健全性 基準チェック /56
Repligenの総株主資本は$2.0B 、総負債は$587.2Mで、負債比率は29.6%となります。総資産と総負債はそれぞれ$2.9Bと$875.6Mです。 Repligenの EBIT は$8.4Mで、利息カバレッジ比率-0.7です。現金および短期投資は$809.1Mです。
主要情報
29.6%
負債資本比率
US$587.21m
負債
| インタレスト・カバレッジ・レシオ | -0.7x |
| 現金 | US$809.15m |
| エクイティ | US$1.99b |
| 負債合計 | US$875.56m |
| 総資産 | US$2.86b |
財務の健全性に関する最新情報
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08
We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Recent updates
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08Is It Time To Consider Buying Repligen Corporation (NASDAQ:RGEN)?
Oct 14Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 28% Above Its Share Price
Sep 08Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)
May 23財務状況分析
短期負債: RGENの 短期資産 ( $1.2B ) が 短期負債 ( $174.3M ) を超えています。
長期負債: RGENの短期資産 ( $1.2B ) が 長期負債 ( $701.3M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: RGEN総負債よりも多くの現金を保有しています。
負債の削減: RGENの負債対資本比率は、過去 5 年間で12%から29.6%に増加しました。
債務返済能力: RGENの負債は 営業キャッシュフロー によって 十分にカバー されています ( 26.4% )。
インタレストカバレッジ: RGEN支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。